122 research outputs found
A p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injury
Background
Many diseases and pathological conditions are characterized by transient or constitutive overproduction of reactive oxygen species (ROS). ROS are causal for ischemia/reperfusion (IR)-associated tissue injury (IRI), a major contributor to organ dysfunction or failure. Preventing IRI with antioxidants failed in the clinic, most likely due to the difficulty to timely and efficiently target them to the site of ROS production and action. IR is also characterized by changes in the activity of intracellular signaling molecules including the stress kinase p38MAPK. While ROS can cause the activation of p38MAPK, we recently obtained in vitro evidence that p38MAPK activation is responsible for elevated mitochondrial ROS levels, thus suggesting a role for p38MAPK upstream of ROS and their damaging effects.<p></p>
Results
Here we identified p38MAPKα as the predominantly expressed isoform in HL-1 cardiomyocytes and siRNA-mediated knockdown demonstrated the pro-oxidant role of p38MAPKα signaling. Moreover, the knockout of the p38MAPK effector MAPKAP kinase 2 (MK2) reproduced the effect of inhibiting or knocking down p38MAPK. To translate these findings into a setting closer to the clinic a stringent kidney clamping model was used. p38MAPK activity increased upon reperfusion and p38MAPK inhibition by the inhibitor BIRB796 almost completely prevented severe functional impairment caused by IR. Histological and molecular analyses showed that protection resulted from decreased redox stress and apoptotic cell death.<p></p>
Conclusions
These data highlight a novel and important mechanism for p38MAPK to cause IRI and suggest it as a potential therapeutic target for prevention of tissue injury.<p></p>
Differential Proteome Analysis of a Flor Yeast Strain under Biofilm Formation
Several Saccharomyces cerevisiae strains (flor yeasts) form a biofilm (flor velum) on the
surface of Sherry wines after fermentation, when glucose is depleted. This flor velum is fundamental
to biological aging of these particular wines. In this study, we identify abundant proteins in the
formation of the biofilm of an industrial flor yeast strain. A database search to enrich flor yeast
“biological process” and “cellular component” according to Gene Ontology Terminology (GO Terms)
and, “pathways” was carried out. The most abundant proteins detected were largely involved
in respiration, translation, stress damage prevention and repair, amino acid metabolism (glycine,
isoleucine, leucine and arginine), glycolysis/gluconeogenesis and biosynthesis of vitamin B9 (folate).
These proteins were located in cellular components as in the peroxisome, mitochondria, vacuole, cell
wall and extracellular region; being these two last directly related with the flor formation. Proteins
like Bgl2p, Gcv3p, Hyp2p, Mdh1p, Suc2p and Ygp1p were quantified in very high levels. This study
reveals some expected processes and provides new and important information for the design of
conditions and genetic constructions of flor yeasts for improving the cellular survival and, thus,
to optimize biological aging of Sherry wine productio
Histamine can be Formed and Degraded in the Human and Mouse Heart
Histamine is metabolized by several enzymes in vitro and in vivo. The relevance of this
metabolism in the mammalian heart in vivo is unclear. However, histamine can exert
positive inotropic effects (PIE) and positive chronotropic effects (PCE) in humans via H2-
histamine receptors. In transgenic mice (H2-TG) that overexpress the human H2 receptor in
cardiomyocytes but not in wild-type littermate mice (WT), histamine induced PIE and PCE
in isolated left or right atrial preparations. These H2-TG were used to investigate the
putative relevance of histamine degrading enzymes in the mammalian heart. Histidine, the
precursor of histamine, increased force of contraction (FOC) in human atrial preparations.
Moreover, histamine increased the phosphorylation state of phospholamban in human
atrium. Here, we could detect histidine decarboxylase (HDC) and histamine itself in
cardiomyocytes of mouse hearts. Moreover, our data indicate that histamine is subject
to degradation in the mammalian heart. Inhibition of the histamine metabolizing enzymes
diamine oxidase (DAO) and monoamine oxidase (MAO) shifted the concentration response
curves for the PIE in H2-TG atria to the left. Moreover, activity of histamine metabolizing
enzymes was present in mouse cardiac samples as well as in human atrial samples. Thus,
drugs used for other indication (e.g. antidepressants) can alter histamine levels in the heart.
Our results deepen our understanding of the physiological role of histamine in the mouse
and human heart. Our findings might be clinically relevant because we show enzyme
targets for drugs to modify the beating rate and force of the human heart
Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
Activation of tissue mast cells (MCs) and their abnormal growth and accumulation in various organs are typically found in primary MC disorders also referred to as mastocytosis. However, increasing numbers of patients are now being informed that their clinical findings are due to MC activation (MCA) that is neither associated with mastocytosis nor with a defined allergic or inflammatory reaction. In other patients with MCA, MCs appear to be clonal cells, but criteria for diagnosing mastocytosis are not met. A working conference was organized in 2010 with the aim to define criteria for diagnosing MCA and related disorders, and to propose a global unifying classification of all MC disorders and pathologic MC reactions. This classification includes three types of `MCA syndromes' (MCASs), namely primary MCAS, secondary MCAS and idiopathic MCAS. MCA is now defined by robust and generally applicable criteria, including (1) typical clinical symptoms, (2) a substantial transient increase in serum total tryptase level or an increase in other MC-derived mediators, such as histamine or prostaglandin D 2, or their urinary metabolites, and (3) a response of clinical symptoms to agents that attenuate the production or activities of MC mediators. These criteria should assist in the identification and diagnosis of patients with MCAS, and in avoiding misdiagnoses or overinterpretation of clinical symptoms in daily practice. Moreover, the MCAS concept should stimulate research in order to identify and exploit new molecular mechanisms and therapeutic targets. Copyright (C) 2011 S. Karger AG, Base
The Role of Protein Crystallography in Defining the Mechanisms of Biogenesis and Catalysis in Copper Amine Oxidase
Copper amine oxidases (CAOs) are a ubiquitous group of enzymes that catalyze the conversion of primary amines to aldehydes coupled to the reduction of O2 to H2O2. These enzymes utilize a wide range of substrates from methylamine to polypeptides. Changes in CAO activity are correlated with a variety of human diseases, including diabetes mellitus, Alzheimer’s disease, and inflammatory disorders. CAOs contain a cofactor, 2,4,5-trihydroxyphenylalanine quinone (TPQ), that is required for catalytic activity and synthesized through the post-translational modification of a tyrosine residue within the CAO polypeptide. TPQ generation is a self-processing event only requiring the addition of oxygen and Cu(II) to the apoCAO. Thus, the CAO active site supports two very different reactions: TPQ synthesis, and the two electron oxidation of primary amines. Crystal structures are available from bacterial through to human sources, and have given insight into substrate preference, stereospecificity, and structural changes during biogenesis and catalysis. In particular both these processes have been studied in crystallo through the addition of native substrates. These latter studies enable intermediates during physiological turnover to be directly visualized, and demonstrate the power of this relatively recent development in protein crystallography
- …